Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)
Taiwan · Delayed Price · Currency is TWD 97.50
+2.00 (2.09%)
Oct 31, 2025, 2:31 PM CST
Gongwin Biopharm Holdings Market Cap
Gongwin Biopharm Holdings has a market cap or net worth of 11.96 billion as of October 31, 2025. Its market cap has decreased by -19.17% in one year.
Market Cap
11.96B
Enterprise Value
10.45B
Revenue
34.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
97.50
Market Cap Chart
Since February 8, 2017, Gongwin Biopharm Holdings's market cap has increased from 8.87B to 11.96B, an increase of 34.84%. That is a compound annual growth rate of 3.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 11.96B | -16.80% |
| Dec 31, 2024 | 14.37B | -31.28% |
| Dec 29, 2023 | 20.91B | -42.13% |
| Dec 30, 2022 | 36.13B | 16.16% |
| Dec 30, 2021 | 31.10B | 17.15% |
| Dec 31, 2020 | 26.55B | 222.07% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 233.43B |
| PharmaEssentia | 184.18B |
| Lotus Pharmaceutical | 77.71B |
| Bora Pharmaceuticals Co., LTD. | 76.71B |
| Lumosa Therapeutics | 34.53B |
| Oneness Biotech | 30.99B |
| Pegavision | 26.56B |
| Polaris Group | 26.43B |